Javier Martín-López

7PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesChemotherapyVision science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 10, 2026
Decoding B-cell Signatures of Complete Pathologic Response to Perioperative Chemoimmunotherapy in Non-Small Cell Lung Cancer.

Belén Sierra-Rodero, Ángeles Gil-González, Marta Molina-Alejandre

|Jan 15, 2026
Minimal Residual Disease Enhances Prognostic Stratification beyond Pathologic Response in Resectable Non-Small Cell Lung Cancer.

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

|Apr 07, 2025
Anemia and lower limbs edemas in a patient with HIV infection.

Francisco Arnaiz de Las Revillas, Javier Martín-López, Milagros Heras-Vicario

|Oct 20, 2024
Perioperative chemoimmunotherapy induces strong immune responses and long-term survival in patients with HLA class I-deficient non-small cell lung cancer.

Marta Molina-Alejandre, Francisco Perea, Virginia Calvo

|Jun 28, 2023
Perioperative Nivolumab and Chemotherapy in Stage III Non-Small-Cell Lung Cancer.

Mariano Provencio, Ernest Nadal, José L González-Larriba

|May 16, 2022
Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non-Small-Cell Lung Cancer (NADIM phase II trial).

Mariano Provencio, Roberto Serna-Blasco, Ernest Nadal

Pageof 2